We are live on ! Find out more
LKFT

Lakefront Biotherapeutics American Depositary Shares
LKFT

82 hedge funds and large institutions have $720M invested in Lakefront Biotherapeutics American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more call options, than puts

Call options by funds: $18.2M | Put options by funds: $15.8M

8% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 26

0.09% more ownership

Funds ownership: 19.54% → 19.64% (+0.09%)

9% less funds holding

Funds holding: 90 → 82 (-8)

9% less capital invested

Capital invested by funds: $793M → $720M (-$73.3M)

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

37% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 19

Holders
82
Holders Change
-8
Holders Change %
-8.89%
% of All Funds
1.38%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.07%
New
12
Increased
28
Reduced
26
Closed
19
Calls
$18.2M
Puts
$15.8M
Net Calls
+$2.39M
Net Calls Change
-$19.6M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$83.1M
2
Jennison Associates
Jennison Associates
New York
+$17.9M
3
Optiver Holding
Optiver Holding
Netherlands
+$17.8M
4
FC
Finepoint Capital
Massachusetts
+$15.4M
5
Citadel Advisors
Citadel Advisors
Florida
+$15.1M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$64.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$31.6M
3
6CM
683 Capital Management
New York
-$20.7M
4
Millennium Management
Millennium Management
New York
-$17.2M
5
APM
Avidity Partners Management
Texas
-$13.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
HM
26
HealthCor Management
New York
$3.08M +$1.87M +31,540 +133%
ECM
27
Endurant Capital Management
California
$2.87M -$58.7K -990 -2%
DCM
28
DAFNA Capital Management
California
$2.38M – – –
CSS
29
Cubist Systematic Strategies
Connecticut
$2.29M -$280K -4,718 -10%
AA
30
ALPS Advisors
Colorado
$2.19M -$1.66M -27,998 -42%
CC
31
Carlson Capital
Texas
$1.95M – – –
AC
32
Apogem Capital
New York
$1.55M +$5.81K +98 +0.4%
Wellington Management Group
33
Wellington Management Group
Massachusetts
$1.52M +$630K +10,619 +64%
Millennium Management
34
Millennium Management
New York
$1.4M -$17.2M -290,123 -92%
OMC
35
Old Mission Capital
Illinois
$1.34M +$1.43M +24,076 New
CCM
36
Cinctive Capital Management
New York
$1.14M -$1.04M -17,619 -46%
Goldman Sachs
37
Goldman Sachs
New York
$1.11M -$2.56M -43,165 -69%
Group One Trading
38
Group One Trading
Illinois
$1.02M +$1.05M +17,628 +2,746%
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$986K +$809K +13,647 +339%
SG Americas Securities
40
SG Americas Securities
New York
$829K +$881K +14,858 New
PCM
41
Prelude Capital Management
New York
$817K -$896K -15,120 -51%
CS
42
Credit Suisse
Switzerland
$733K +$779K +13,135 New
HS
43
HighVista Strategies
Massachusetts
$658K -$83.5K -1,408 -11%
Geode Capital Management
44
Geode Capital Management
Massachusetts
$563K +$236K +3,988 +65%
CPM
45
Connective Portfolio Management
New York
$558K – – –
Calamos Advisors
46
Calamos Advisors
Illinois
$554K -$37.1K -625 -6%
Wells Fargo
47
Wells Fargo
California
$531K +$32.8K +554 +6%
American Century Companies
48
American Century Companies
Missouri
$499K +$133K +2,238 +33%
BFM
49
Boothbay Fund Management
New York
$489K – – –
GF
50
Gabelli Funds
New York
$466K +$110K +1,850 +28%
1
2
3 4

LKFT Hedge Fund Activity: Q2 2022 in Review

82 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q2 2022, worth a combined $720M — down 9.2% from $793M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of LKFT and 12 opened new positions — a net loss of 7 holders — while 26 trimmed existing stakes and 28 added.

The largest buyer was Fidelity Investments, adding an estimated $83.1M. The largest seller was BVF Inc, exiting entirely with an estimated $64.9M sold.

  • 82 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q2 2022, down from 90 in Q1 2022.
  • Funds reported $720M of Lakefront Biotherapeutics American Depositary Shares stock for Q2 2022, down 9.2% quarter-over-quarter.
  • 12 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q2 2022 and 19 closed out, a net change of -7 holders.
  • The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q2 2022 was Fidelity Investments, an estimated $83.1M added.
  • The largest Lakefront Biotherapeutics American Depositary Shares seller in Q2 2022 was BVF Inc, an estimated $64.9M sold.

Based on aggregated 13F filings for Q2 2022.